Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Clinical studies on-going on LP01+LPC09+Bb1 and other actives in prostate health
Mogna L. et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? (LPC09, LA02, LP01, LRE02, BR03, BL03) J Clin Gastroenterol. 2014; 48 Suppl:S91-95.
+ Internal data on anti-inflammatory and anti-oxidant properties available upon request on certain strains